Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

PRN News Releases

Feb 26, 2021 06:00 ET
Hani Zeini Grant for Meritorious College or University Students
MIAMI, Feb. 26, 2021 /PRNewswire-PRWeb/ -- Hani Zeini Grant for accredited college and university students is available now. Detailed information for the program is accessible on the official website....
Feb 26, 2021 06:00 ET
Lilly announces additional doses of neutralizing antibody therapy purchased by U.S. government to treat COVID-19
INDIANAPOLIS, Feb. 26, 2021 /PRNewswire/ -- The U.S. government has agreed to purchase a minimum of 100,000 doses of bamlanivimab (LY-CoV555) 700 mg and etesevimab (LY-CoV016) 1400 mg together, Eli Lilly and Company (NYSE: LLY) announced. Bamlanivimab and etesevimab together recently received emergency use authorization for the treatment of recently diagnosed, mild to moderate COVID-19 in patients who are at high risk of progressing to severe COVID-19 and/or hospitalization. Additionally, the National Institutes of Health (NIH) recently updated the COVID-19 Treatment Guidelines to recommend ...
Feb 26, 2021 06:00 ET
LogRhythm Launches New Programs to Better Support Customers, Employees and the Community
BOULDER, Colo., Feb. 26, 2021 /PRNewswire-PRWeb/ -- LogRhythm, the company powering today's security operations centers (SOCs), announced multiple areas of growth as a result of customer- and employee-centric initiatives implemented in 2020. These include increases in the amount of data being protected by customers using the LogRhythm NextGen SIEM Platform and the introduction of new programs designed to promote holistic employee well-being. In addition to supporting customers' and employees' successes during challenging times, these initiatives also fueled the business and laid the groundwo...
Feb 26, 2021 06:00 ET
Megatel Homes to Build Approximately $30M Development
DALLAS, Feb. 26, 2021 /PRNewswire/ -- Megatel Homes LLC, one of the largest private homebuilders in the country, today announced that the company has secured a 116-lot subdivision for Pleasant Run Estates, a residential development located in Ellis County, directly south of Dallas. Once developed, the approximately $30 million development will feature 116 single-family homes....
Feb 26, 2021 06:00 ET
nference and Mayo Clinic Study Shows Childhood and Adult Vaccinations May Provide Defense Against COVID-19
ROCHESTER, Minn. and CAMBRIDGE, Mass., Feb. 26, 2021 /PRNewswire/ -- nference, the biomedical technology company, today announced publication in Scientific Reports of a study that analyzes Mayo Clinic data with nference artificial intelligence software and reveals potential cross-protective effects of existing vaccines against Covid-19 infection. The analysis indicates that individuals who previously received a number of traditional vaccines, such as for polio, measles, and flu, have a reduced risk of testing positive for SARS-CoV-2, likely as a result of "immune training," whereby innate im...
Feb 26, 2021 06:00 ET
Oncolytics Biotech® to Host Conference Call to Discuss Fourth Quarter and Full Year Financial Results and Operational Highlights
SAN DIEGO, Calif. and CALGARY, AB, Feb. 26, 2021 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that it will host a conference call and webcast on Friday, March 5, 2021, at 8:30 am ET to discuss a corporate update and financial results for the fourth quarter and full year 2020....
Feb 26, 2021 06:00 ET
PepGen Announces Formation of Scientific Advisory Board
BOSTON and OXFORD, United Kingdom, Feb. 26, 2021 /PRNewswire/ -- PepGen, an emerging biotechnology company focused on transforming the care of patients with neuromuscular diseases through the enhanced delivery of therapeutic oligonucleotides, today announced the formation of its Scientific Advisory Board (SAB). Company founder Matthew Wood, M.D., Ph.D. will lead the board as Chairman, and is joined by Art Krieg, M.D., Elizabeth McNally, M.D., Ph.D., Charles Thornton, M.D., Jonathon Watts, Ph.D., and Brenda Wong, M.D. This eminent group of scientists, clinicians and thought leaders will bring...
Feb 26, 2021 06:00 ET
Poema Global Holdings Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants Commencing February 26, 2021
BERLIN and HONG KONG, Feb. 26, 2021 /PRNewswire/ -- Poema Global Holdings Corp. (Nasdaq: PPGH.U) (the "Company") announced that, commencing February 26, 2021, holders of the units sold in the Company's initial public offering of 34,500,000 units, completed on January 8, 2021 may elect to separately trade the Class A ordinary shares and warrants included in the units. Any units not separated will continue to trade on the Nasdaq Capital Market ("Nasdaq") under the symbol "PPGH.U," and the separated Class A ordinary shares and warrants are expected to trade on Nasdaq under the symbols "PPGH" an...
Feb 26, 2021 06:00 ET
Puxin Announces US$69 Million Private Placement of Convertible Notes
BEIJING, Feb. 26, 2021 /PRNewswire/ -- Puxin Limited (NYSE: NEW) ("Puxin" or the "Company"), a successful consolidator of the after-school education industry in China, today announced that it has entered into convertible note purchase agreements with a group of institutional investors (the "Purchasers"), pursuant to which Puxin will issue and sell convertible notes in an aggregate principal amount of US$69 million through a private placement to the Purchasers. The transaction is subject to the satisfaction of customary closing conditions....
Feb 26, 2021 06:00 ET
Roivant Grows Computational Drug Discovery Engine with Acquisition of Silicon Therapeutics
NEW YORK and BOSTON and BASEL, Switzerland, Feb. 26, 2021 /PRNewswire/ -- Roivant Sciences today announced it has entered into a definitive agreement to acquire Silicon Therapeutics for $450 million in Roivant equity, with additional potential regulatory and commercial milestone payments. ...
Feb 26, 2021 06:00 ET
Sub-Zero and Wolf Unveil New Products and Design Innovations in Virtual Showcase
MADISON, Wis., Feb. 26, 2021 /PRNewswire/ -- Sub-Zero Group, Inc., the leading manufacturer of premium refrigeration, cooking equipment, and dishwashing brands Sub-Zero, Wolf, and Cove, has expanded its offering with the launch of four new products unveiled in their first-ever virtual showcase.  The new appliances reinforce an unparalleled commitment to the quality, performance, and purposeful innovation the storied brands have come to represent since the company's founding over 75 years ago. ...
Feb 26, 2021 06:00 ET
The Law Offices of Frank R. Cruz Announces Investigation of Energizer Holdings, Inc. (ENR) on Behalf of Investors
LOS ANGELES, Feb. 26, 2021 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces an investigation of Energizer Holdings, Inc. ("Energizer" or the "Company") (NYSE: ENR) on behalf of investors concerning the Company's possible violations of federal securities laws....
Feb 26, 2021 06:00 ET
Two Missouri Schools And Home State Health Participate In National No One Eats Alone Day
ST. LOUIS, Feb. 26, 2021 /PRNewswire/ -- A positive prevention initiative designed to promote inclusion among students was celebrated this year virtually across two schools this month with the help of Home State Health. The schools included Scott County Central and Puxico R-8.  ...
Feb 26, 2021 05:55 ET
Sempra Energy And Sempra Energy Foundation To Support Winter Storm Relief In Texas
SAN DIEGO, Feb. 26, 2021 /PRNewswire/ -- Sempra Energy (NYSE: SRE) today announced that the Sempra Energy Foundation is pledging $1 million to assist communities in Texas recovering from the unprecedented winter storm that blanketed the state. This builds on a $250,000 donation by Sempra Energy for food relief in Houston and Southeast Texas and will bolster a $1 million donation by Oncor Electric Delivery Company LLC (Oncor), of which Sempra Energy is a majority owner, to community organizations within its service territory. ...
Feb 26, 2021 05:50 ET
Haemonetics To Present At The Jefferies Plasma Summit
BOSTON, Feb. 26, 2021 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will present at the Jefferies Plasma Summit on Thursday, March 11, 2021, at 10:45 a.m. ET....
Feb 26, 2021 05:46 ET
Feb 26, 2021 05:45 ET
Foot Locker, Inc. Reports 2020 Fourth Quarter And Full Year Results
NEW YORK, Feb. 26, 2021 /PRNewswire/ -- Foot Locker, Inc. (NYSE: FL), the New York-based specialty athletic retailer, today reported financial results for its fourth quarter and fiscal year ended January 30, 2021....
Feb 26, 2021 05:42 ET
Dutch invention results in 47% less malaria
WAGENINGEN, Netherlands, Feb. 26, 2021 /PRNewswire/ -- Ground-breaking news for malaria control. With a simple ventilation tube, the EaveTubes, the Dutch inventor Anne Osinga of In2Care, was able to reduce malaria by 47 percent in Ivory Coast. The renowned international medical journal The Lancet publishes the results of a scientific study on this invention today. The research was supported by the Bill & Melinda Gates Foundation....
Feb 26, 2021 05:40 ET
CHMP Adopts Positive Opinion for Evrysdi™ for the Treatment of Spinal Muscular Atrophy in Adults and Children Aged Two Months and Older
SOUTH PLAINFIELD, N.J., Feb. 26, 2021 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT), today announced that the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended the approval of Evrysdi™ (risdiplam) for the treatment of 5q spinal muscular atrophy (SMA) in patients 2 months and older, with a clinical diagnosis of SMA Type 1, Type 2 or Type 3 with one to four SMN2 copies. The CHMP review was completed under the accelerated assessment pathway, which is offered to medicines deemed to be of major interest for public health and therapeutic ...
Feb 26, 2021 05:35 ET
DesignRush Editors Reveal the Second List of the Best Agencies to Work With In 2021 [Focus on Digital Marketing]
NEW YORK, Feb. 26, 2021 /PRNewswire-PRWeb/ -- An average internet user spends almost 7 hours per day surfing the internet across all devices. Almost two-thirds of the global users go online looking for information and/or solutions to their unmet needs. ...